Last updated on April 2018

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies


Brief description of study

This is a standard of care treatment guideline for allogeneic hematopoetic stem cell transplant (HSCT) in patients with primary immune deficiencies.

Detailed Study Description

Based on diagnosis and clinical history, a determination of the most appropriate regimen will be made based on the following prep plans:

Arm A: Fully Myeloablative Preparative Regimen, Arm B: Reduced Toxicity Ablative Preparative Regimen, Arm C: Reduced Intensity Conditioning, Arm D: No Preparative Regimen

Clinical Study Identifier: NCT01652092

Contact Investigators or Research Sites near you

Start Over

Angela R. Smith, M.D.

Masonic Cancer Center, University of Minnesota
Minneapolis, MN United States
  Connect »